ABT vs CZNC · P/E 25, rev $44.33B vs P/E 11, rev $82.2M
Abbott Laboratories (ABT) versus Citizens & Northern Corp (CZNC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Citizens & Northern Corp (CZNC) is a banks - regional company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CZNC revenue for 2026-06-30 was $82.2M. Net income was $14.3M. CZNC currently screens at market cap $296.3M and trailing P/E 10.9.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CZNC currently screens at market cap $296.3M and trailing P/E 10.9.
Not investment advice. Open the ABT and CZNC stock pages for the full models.
Not investment advice.